A snapshot of the Indian pharma industry

$49.99

An analysis of the Indian pharma industry

Category:
Description

An analysis of the Indian pharma industry

Slides in the pack:

  1. The Indian pharmaceutical market is dominated by generics and is seeing heady growth
  2. Pharmaceuticals are among India’s fastest growing industries
  3. Anti-infectives form the largest chunk of the Indian pharma market by value
  4. India occupies a remarkable competitive position within the global pharmaceutical exports business
  5. The relatively cheap skilled labour available in India gives it an edge in the labour and capital intensive pharma industry
  6. The Hatch- Waxman Act regulates generic drugs manufactured in India entering the American market
  7. The Hatch- Waxman Act led to India’s ascent as a provider of generics to the US market
  8. Government regulations impacting Indian pharmaceutical industry
  9. Notable trends in the Indian pharmaceuticals sector
  10. Trends in sales, exports, and R & D
  11. Overview of the medical devices market in India
  12. Top 20 pharmaceutical companies in India
  13. Deals in Indian pharma post 2003
  14. Health tourism: the fastest growing sub-sector of the Indian healthcare industry
  15. Health tourism in India is mostly centered around cosmetic surgery
  16. There has been a steady growth in expenditure on drugs in the local market
  17. Public and private spending in the Indian pharma and health care sector is steadily mounting
  18. Health insurance has always been critical to the growth of healthcare
  19. National health insurance schemes finance most of India’s healthcare needs
  20. The central government scheme for BPL card holders:
    Rashtriya Swasthya Bima Yojana
  21. Insurance scheme in Karnataka for BPL card holders: Vajpayee Arogya Suvarna scheme
  22. Insurance scheme in Gujarat for BPL card holders: Mukhyamantri Amrutam Yojana
  23. Health insurance policies by top private sector insurers in India
  24. Diseases in India ranked by revenue, number of patients and level of commercial activity
  25. Landscape of unmet needs: diseases that cause the most deaths in India
  26. Landscape of unmet needs: diseases that cause the most number of untimely deaths in India
  27. Landscape of unmet needs: diseases that cause the most disability in India
  28. Landscape of unmet needs: diseases that cause the most death and disability (combined) in India
  29. Landscape of unmet needs: risk factors that drive the most death and disability in India
  30. Unmet needs landscape: change in ranking of diseases by prevalence
  31. The medical training system in India is organized under the Indian Medical Council
  32. Only under a quarter of Indian healthcare workers have a medical qualification
  33. Strengths and weaknesses of India’s healthcare sector

 

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “A snapshot of the Indian pharma industry”

Your email address will not be published. Required fields are marked *